Literature DB >> 26436133

NADPH Oxidases in Chronic Liver Diseases.

Joy X Jiang1, Natalie J Török1.   

Abstract

Oxidative stress is a common feature observed in a wide spectrum of chronic liver diseases including viral hepatitis, alcoholic, and nonalcoholic steatohepatitis. The nicotinamide adenine dinucleotide phosphate (NADPH) oxidases (NOXs) are emerging as major sources of reactive oxygen species (ROS). Several major isoforms are expressed in the liver, including NOX1, NOX2, and NOX4. While the phagocytic NOX2 has been known to play an important role in Kupffer cell and neutrophil phagocytic activity and inflammation, the nonphagocytic NOX homologues are increasingly recognized as key enzymes in oxidative injury and wound healing. In this review, we will summarize the current advances in knowledge on the regulatory pathways of NOX activation, their cellular distribution, and their role in the modulation of redox signaling in liver diseases.

Entities:  

Year:  2014        PMID: 26436133      PMCID: PMC4591547          DOI: 10.1155/2014/742931

Source DB:  PubMed          Journal:  Adv Hepatol        ISSN: 2314-7709


  82 in total

1.  Sp1 and Sp3 transcription factors mediate leptin-induced collagen α1(I) gene expression in primary culture of male rat hepatic stellate cells.

Authors:  Inmaculada García-Ruiz; Erica Gómez-Izquierdo; Teresa Díaz-Sanjuán; Montserrat Grau; Pablo Solís-Muñoz; Teresa Muñoz-Yagüe; José A Solís-Herruzo
Journal:  Endocrinology       Date:  2012-10-23       Impact factor: 4.736

2.  Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism.

Authors:  Michihiro Matsumoto; Seongah Han; Tadahiro Kitamura; Domenico Accili
Journal:  J Clin Invest       Date:  2006-08-10       Impact factor: 14.808

3.  Advanced glycation endproducts induce fibrogenic activity in nonalcoholic steatohepatitis by modulating TNF-α-converting enzyme activity in mice.

Authors:  Joy X Jiang; Xiangling Chen; Hiroo Fukada; Nobuko Serizawa; Sridevi Devaraj; Natalie J Török
Journal:  Hepatology       Date:  2013-08-06       Impact factor: 17.425

4.  Ethanol-induced expression of ET-1 and ET-BR in liver sinusoidal endothelial cells and human endothelial cells involves hypoxia-inducible factor-1alpha and microrNA-199.

Authors:  Samantha Yeligar; Hidekazu Tsukamoto; Vijay K Kalra
Journal:  J Immunol       Date:  2009-09-25       Impact factor: 5.422

5.  Hepatitis C virus (HCV) proteins induce NADPH oxidase 4 expression in a transforming growth factor beta-dependent manner: a new contributor to HCV-induced oxidative stress.

Authors:  Howard E Boudreau; Suzanne U Emerson; Agnieszka Korzeniowska; Meghan A Jendrysik; Thomas L Leto
Journal:  J Virol       Date:  2009-10-07       Impact factor: 5.103

6.  Matricellular protein CCN1 promotes regression of liver fibrosis through induction of cellular senescence in hepatic myofibroblasts.

Authors:  Ki-Hyun Kim; Chih-Chiun Chen; Ricardo I Monzon; Lester F Lau
Journal:  Mol Cell Biol       Date:  2013-03-18       Impact factor: 4.272

Review 7.  The FoxO code.

Authors:  D R Calnan; A Brunet
Journal:  Oncogene       Date:  2008-04-07       Impact factor: 9.867

Review 8.  Iron and CYP2E1-dependent oxidative stress and toxicity.

Authors:  Arthur I Cederbaum
Journal:  Alcohol       Date:  2003-06       Impact factor: 2.405

9.  Ethanol and arachidonic acid synergize to activate Kupffer cells and modulate the fibrogenic response via tumor necrosis factor alpha, reduced glutathione, and transforming growth factor beta-dependent mechanisms.

Authors:  Francisco Javier Cubero; Natalia Nieto
Journal:  Hepatology       Date:  2008-12       Impact factor: 17.425

10.  NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development.

Authors:  Patricia Sancho; Jèssica Mainez; Eva Crosas-Molist; César Roncero; Conrado M Fernández-Rodriguez; Fernando Pinedo; Heidemarie Huber; Robert Eferl; Wolfgang Mikulits; Isabel Fabregat
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

View more
  15 in total

1.  Design, synthesis, and biological evaluation of inhibitors of the NADPH oxidase, Nox4.

Authors:  Qian Xu; Amol A Kulkarni; Ayyiliath M Sajith; Dilbi Hussein; David Brown; Osman F Güner; M Damoder Reddy; E Blake Watkins; Bernard Lassègue; Kathy K Griendling; J Phillip Bowen
Journal:  Bioorg Med Chem       Date:  2017-12-17       Impact factor: 3.641

2.  Editorial: dark chocolate may improve NAFLD and metabolic syndrome by reducing oxidative stress.

Authors:  H Malhi; R Loomba
Journal:  Aliment Pharmacol Ther       Date:  2016-09       Impact factor: 8.171

3.  NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice.

Authors:  Shuang Liang; Hsiao-Yen Ma; Zhenyu Zhong; Debanjan Dhar; Xiao Liu; Jun Xu; Yukinori Koyama; Takahiro Nishio; Daniel Karin; Gabriel Karin; Ryan Mccubbin; Cuili Zhang; Ronglin Hu; Guizhi Yang; Li Chen; Souradipta Ganguly; Tian Lan; Michael Karin; Tatiana Kisseleva; David A Brenner
Journal:  Gastroenterology       Date:  2018-11-13       Impact factor: 22.682

Review 4.  Non-alcoholic Fatty Liver Disease and Liver Fibrosis during Aging.

Authors:  Yuan Li; Nia T Adeniji; Weiguo Fan; Koshi Kunimoto; Natalie J Török
Journal:  Aging Dis       Date:  2022-07-11       Impact factor: 9.968

5.  Expression of genes that encode cellular oxidant/antioxidant systems are affected by heat stress.

Authors:  Walid S Habashy; Marie C Milfort; Romdhane Rekaya; Samuel E Aggrey
Journal:  Mol Biol Rep       Date:  2018-04-04       Impact factor: 2.316

Review 6.  The Role of NADPH Oxidases (NOXs) in Liver Fibrosis and the Activation of Myofibroblasts.

Authors:  Shuang Liang; Tatiana Kisseleva; David A Brenner
Journal:  Front Physiol       Date:  2016-02-02       Impact factor: 4.566

Review 7.  Does Hypoxia Cause Carcinogenic Iron Accumulation in Alcoholic Liver Disease (ALD)?

Authors:  Inês Silva; Vanessa Rausch; Helmut-Karl Seitz; Sebastian Mueller
Journal:  Cancers (Basel)       Date:  2017-10-25       Impact factor: 6.639

Review 8.  Collaborative Power of Nrf2 and PPARγ Activators against Metabolic and Drug-Induced Oxidative Injury.

Authors:  Choongho Lee
Journal:  Oxid Med Cell Longev       Date:  2017-08-27       Impact factor: 6.543

9.  Digoxin Suppresses Pyruvate Kinase M2-Promoted HIF-1α Transactivation in Steatohepatitis.

Authors:  Xinshou Ouyang; Sheng-Na Han; Ji-Yuan Zhang; Evangelos Dioletis; Balazs Tamas Nemeth; Pal Pacher; Dechun Feng; Ramon Bataller; Joaquin Cabezas; Peter Stärkel; Joan Caballeria; Rebecca LePine Pongratz; Shi-Ying Cai; Bernd Schnabl; Rafaz Hoque; Yonglin Chen; Wei-Hong Yang; Irma Garcia-Martinez; Fu-Sheng Wang; Bin Gao; Natalie Julia Torok; Richard Glenn Kibbey; Wajahat Zafar Mehal
Journal:  Cell Metab       Date:  2018-02-06       Impact factor: 27.287

10.  MicroRNA-223 ameliorates alcoholic liver injury by inhibiting the IL-6-p47phox-oxidative stress pathway in neutrophils.

Authors:  Man Li; Yong He; Zhou Zhou; Teresa Ramirez; Yueqiu Gao; Yanhang Gao; Ruth A Ross; Haixia Cao; Yan Cai; Mingjiang Xu; Dechun Feng; Ping Zhang; Suthat Liangpunsakul; Bin Gao
Journal:  Gut       Date:  2016-09-27       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.